医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
CBIO · CRESCENT BIOPHARMA, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
CRESCENT BIOPHARMA, INC.（CBIO）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 $12.4M、卖出 $286K；高管董事有效买入 $12.4M、有效卖出 —。最近申报 2026-09-18。
买入 Bought$12.4M
卖出 Sold$286K
有效买入 Effective bought$12.4M
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-16 | Bispham Barbara Harlin See Remarks | 卖出 Sell | 620 | $17.90 | $11K | SEC |
| 2026-09-16 | Brumm Joshua T Chief Executive Officer, Director | 卖出 Sell | 9,447 | $16.91 | $160K | SEC |
| 2026-09-16 | McNeill Jonathan President and COO | 卖出 Sell | 4,570 | $16.90 | $77K | SEC |
| 2026-09-16 | Scalzo Richard William Chief Financial Officer | 卖出 Sell | 568 | $17.90 | $10K | SEC |
| 2026-09-16 | Im Ellie Eunkyung Chief Medical Officer | 卖出 Sell | 623 | $17.90 | $11K | SEC |
| 2026-09-16 | Pinkas Jan Chief Scientific Officer | 卖出 Sell | 658 | $17.90 | $12K | SEC |
| 2026-09-16 | Lynch Ryan See Remarks | 卖出 Sell | 240 | $17.90 | $4K | SEC |
| 2026-07-16 | Fairmount Funds Management LLC 10% Owner, Director | 买入 Buy · 有效 | 853,450 | $14.50 | $12.4M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-18 | Brumm Joshua T Officer, Director | 9,013 | $155K | 10b5-1 |
| 2026-09-18 | McNeill Jonathan Officer | 4,415 | $76K | 10b5-1 |
| 2026-09-16 | Brumm Joshua T Officer, Director | 1,771 | $33K | 10b5-1 |
| 2026-09-16 | McNeill Jonathan Officer | 804 | $15K | 10b5-1 |
内部人 Insiders
Bispham Barbara Harlin、Brumm Joshua T、McNeill Jonathan、Scalzo Richard William、Im Ellie Eunkyung、Pinkas Jan、Lynch Ryan、Fairmount Funds Management LLC